Tuberculosis Meningo-encephalitis in Casablanca, Morocco
Jean Claude Majambere1, Fatima Zahra Aznag2, Latifa Marih2
1Laboratory of clinical immunology, infection and autoimmunity, FMPC, Hassan II University, Casablanca, Morocco.
La Tunisie Medicale
|March 15, 2026
Summary
Tuberculous meningoencephalitis, a severe form of Mycobacterium tuberculosis infection, presents diverse symptoms. Early diagnosis and treatment are crucial for improving patient outcomes and reducing mortality and neurological sequelae.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- Neuromeningeal tuberculosis is a severe manifestation of Mycobacterium tuberculosis infection.
- Diagnosis is challenging due to varied clinical presentations and non-specific radiological findings, often leading to delayed treatment.
Purpose of the Study:
- To characterize the epidemiological profile of confirmed Tuberculous Meningo-encephalitis.
- To identify predictors of mortality and neurological sequelae in patients with Tuberculous Meningo-encephalitis.
Main Methods:
- A retrospective, descriptive, and analytical study of 90 patients diagnosed with Tuberculous Meningo-encephalitis between 2015 and 2018.
- Statistical analyses, including multivariate logistic regression, were employed to determine factors associated with adverse outcomes.
Main Results:
- The study included 90 patients, with a mean age of 38 years; 58% were male. Low socioeconomic status (90%) and recent tuberculosis contact (13.3%) were significant risk factors.
- Common symptoms included fever (97.4%), headache (70%), and stiff neck (58%). Tuberculous Meningo-encephalitis occurred in 59.9% of cases.
- Cerebrospinal fluid analysis revealed lymphocytic pleocytosis, elevated protein, and low glucose. Mycobacterium tuberculosis was confirmed by culture (85%) and RT-PCR (87.5%).
- Delayed diagnosis, hydrocephalus, and the meningoencephalitis form were independently linked to mortality or neurological sequelae.
Conclusions:
- Tuberculous meningoencephalitis exhibits significant clinical, biological, and radiological diversity.
- Prognosis is strongly influenced by the promptness of diagnosis and initiation of treatment.
Related Concept Videos
Pulmonary Tuberculosis IV
612
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
612
Pulmonary Tuberculosis I
1.2K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.2K
Pulmonary Tuberculosis II
1.9K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.9K
Pulmonary Tuberculosis V
730
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
730
Pulmonary Tuberculosis III
1.3K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.3K


